Open AccessPathologic complete response to neoadjuvant anti-HER2 therapy is associated with HER2 immunohistochemistry score in HER2-positive early breast cancer
Author(s) -
Hailong Chen,
Qiang Chen,
Yongchuan Deng
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000027632
Subject(s) - immunohistochemistry , medicine , breast cancer , odds ratio , trastuzumab , oncology , confidence interval , cancer